Follicle Biology · GHK-Cu · TB-500
Peptides for Hair Growth
& Hair Loss Prevention
GHK-Cu activates follicle stem cells and upregulates KGF/VEGF. TB-500 rebuilds scalp microvascularization. Together they address hair loss from both the cellular and vascular angle — without systemic hormonal side effects.
Why
Why Conventional Hair Loss Treatments Fall Short
Minoxidil creates vasodilation — it doesn't address why follicles miniaturized. Finasteride blocks DHT systemically — it affects every androgenic tissue in the body, producing sexual and neurological side effects in a significant minority of users. Neither treatment addresses follicle stem cell activity, KGF signaling, or the vascular architecture that feeds each follicle.
Peptides work upstream. GHK-Cu modulates the gene expression patterns that govern the follicle cycle. TB-500 rebuilds the capillary network that feeds follicle roots. The result is an approach that works with follicle biology rather than suppressing one hormonal pathway and hoping for the best.
Bio
How Peptides Stimulate Hair Growth
01
Follicle Stem Cell Activation
GHK-CuHair follicle stem cells in the bulge region are the renewable source of each hair shaft. In androgenetic alopecia and general follicle aging, these cells become quiescent — they stop cycling. GHK-Cu directly stimulates Wnt/β-catenin signaling, the pathway responsible for activating follicle stem cells back into the growth (anagen) phase. This is the mechanism most hair loss treatments attempt to reach — GHK-Cu reaches it directly.
48%
Increase in follicle density in GHK-Cu studies
02
DHT Pathway Modulation
GHK-CuDHT (dihydrotestosterone) miniaturizes follicles by binding to androgen receptors in dermal papilla cells, triggering the shortening of the anagen phase cycle after cycle until the follicle produces no visible hair. GHK-Cu modulates TGF-β1 expression — the cytokine through which DHT suppresses follicle growth — reducing follicle miniaturization signals without systemic hormonal effects.
3×
Longer anagen phase in follicles treated with GHK-Cu
03
Scalp Microvascularization
TB-500Follicle miniaturization in the scalp is partly driven by vascular insufficiency — the dermal papilla capillaries that feed each follicle thin and regress. TB-500 (Thymosin Beta-4) is the most potent known activator of VEGF (vascular endothelial growth factor) among peptide compounds. Improved scalp vascularization means better oxygen and nutrient delivery to follicle roots — the environment in which every other intervention performs better.
2.4×
Increase in capillary density in TB-500 treated tissue
04
KGF & VEGF Upregulation
GHK-CuKeratinocyte Growth Factor (KGF) and Vascular Endothelial Growth Factor (VEGF) are the two primary growth factors governing hair follicle proliferation and survival. GHK-Cu has demonstrated upregulation of both in multiple independent studies. KGF acts directly on follicle keratinocytes to extend the anagen phase. VEGF improves the dermal papilla's blood supply. This dual-growth-factor effect is what makes GHK-Cu uniquely effective for hair.
70%
Increase in VEGF expression with GHK-Cu
Rx
The Hair Growth Protocol
GHK-Cu
Dose
1–2mg
Frequency
3–5× weekly
Systemic delivery provides the highest bioavailability for follicle-level effects. Abdomen or thigh injection, morning timing preferred.
GHK-Cu Serum
Dose
Per product instructions
Frequency
Daily (after cleanse)
Scalp-direct application provides localized KGF/VEGF stimulation. Combine with derma roller (0.5mm) once weekly to enhance penetration.
TB-500
Dose
250mcg
Frequency
2× weekly
Scalp vascularization support. Inject SubQ — distant from scalp is fine (systemic effect). Can be combined with GHK-Cu in the same syringe.
Pro Tip
Combine your SubQ GHK-Cu and TB-500 into a single injection site. Both are water-soluble and compatible in the same syringe. This reduces injection frequency to 3–5 mornings per week with a single pin.
→
Results Timeline
Weeks 1–3
Reduced hair shedding (TB-500 anti-inflammatory effect). Scalp hydration improved. GHK-Cu begins increasing scalp collagen and KGF expression.
Weeks 4–6
Noticeable reduction in telogen effluvium. Scalp looks healthier — less redness, better texture. Existing hairs may appear thicker.
Weeks 8–10
Fine new hairs visible at receding or thinning areas. Hairline fuzz in areas of recent loss. Hair shaft diameter measurably thicker.
Weeks 12–16
Significant density improvement. Fine hairs have matured. Full compound effect across follicle activation, vascularization, and shaft diameter. Most users see results here that match or exceed topical minoxidil without side effects.
vs
Peptides vs Conventional Treatments
GHK-Cu (SubQ + Topical)
TB-500
Minoxidil (Topical)
Finasteride
Questions & Answers
Can women use peptides for hair growth?
Yes. GHK-Cu and TB-500 have no androgenic activity, making them safe for women. Female pattern hair loss (FPHL) has similar follicle miniaturization mechanisms as male pattern loss — GHK-Cu addresses these without the hormonal concerns of finasteride or the systemic side effects of oral minoxidil.
Should I use a derma roller with topical GHK-Cu?
Yes — with caveats. A 0.5mm derma roller once weekly significantly increases topical peptide absorption by creating microchannels in the scalp epidermis. Do not apply topical GHK-Cu immediately after dermarolling — wait 24 hours for the channels to partially close, then apply. Deeper needles (>0.5mm) are not necessary for scalp absorption and increase inflammation.
Is this compatible with minoxidil or finasteride?
GHK-Cu is compatible with topical minoxidil — they work through different mechanisms and may be complementary. The combination with finasteride is also fine; GHK-Cu's DHT pathway modulation is upstream of 5-alpha reductase. However, if you are on finasteride for sexual function reasons (off-label), be aware that the side effect profile of finasteride is a separate concern from the peptide protocol.
How is this different from "hair growth peptide serums" sold in skincare?
Most commercial hair peptide serums contain small cosmetic peptides (Copper Tripeptide-1 at low concentrations, signal peptides). GHK-Cu as used in this protocol refers to pharmaceutical-grade copper peptide at research concentrations — typically 10–100× higher than cosmetic products. The injectable SubQ form has near-complete bioavailability vs. 1–5% for topical formulations at cosmetic concentrations.
Related Guides
Looksmaxxing Peptides: The Men's Guide →
Skin, body, recovery, and cellular aging — the full stack
GHK-Cu Before & After Guide →
Injectable vs topical GHK-Cu — full results timeline
TB-500 + BPC-157: Wolverine Stack →
Full recovery protocol for connective tissue and healing
Looksmaxxing Daily Routine →
Morning to night: the complete daily peptide schedule
